ClinicalTrials.Veeva

Menu

A Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy

G

Guangzhou Medical University

Status

Enrolling

Conditions

Sublobar Resection
Lung Cancer (Diagnosis)
Lobectomy

Study type

Observational

Funder types

Other

Identifiers

NCT07288710
GMU-LC-202511

Details and patient eligibility

About

The trial was designed as a single-center, non-interventional, prospective observational study to explore the role of a multimodal digital device in analyzing subjective and objective recovery in lung cancer patients undergoing sublobar resection versus lobectomy.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. adult patients (age ≥ 18 years)
  2. American Society of Anesthesiologists (ASA) grade of III or below
  3. scheduled for VATS from March to December 2023

Exclusion criteria

  1. age <18 years
  2. inability or poor compliance to use wearable devices
  3. lack of smartphone
  4. incomplete digital device data during hospitalization
  5. patients with lymph node or distant metastasis

Trial design

300 participants in 2 patient groups

Sublobar Resection Group
Description:
Patients in this group underwent sublobar resection (including segmentectomy or wedge resection). The decision for patients to receive this surgical procedure was similarly based on their routine clinical assessment, disease characteristics, physician's recommendation, and informed consent. It was not a result of randomization or active intervention by the investigators. This study will prospectively observe the post-operative recovery and prognosis of these patients, comparing them to the lobectomy group.
Lobectomy Group
Description:
Patients in this group underwent standard lobectomy. The decision for patients to receive this surgical procedure was based on their routine clinical assessment, diagnosis, disease staging, physician's recommendation, and informed consent. It was not a result of randomization or active intervention by the investigators. This study will prospectively observe the post-operative recovery and prognosis of these patients.

Trial contacts and locations

1

Loading...

Central trial contact

Jianxing He, M.D.; Hengrui Liang, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems